Citadel Advisors »

Palvella Therapeutics Inc Ne shares owned by Citadel Advisors

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $276k 2.6k 104.67
2024-12-31 $125k 10k 12.00

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Palvella Therapeutics Inc Ne

Suvretta Capital Management
BVF
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
State Street Corporation
Summit Partners Public Asset Management
Jennison Associates
Federated Investors
Woodline Partners
Alliancebernstein
Perceptive Advisors
FMR
Artisan Partners Limited Partnership

View all funds holding Palvella Therapeutics Inc Ne